Neurocognitive Outcome and Compensating Possibilities in Children and Adolescents Treated for Acute Lymphoblastic Leukemia With Chemotherapy Only.

To examine the neurocognitive outcomes in children and adolescents with acute lymphoblastic leukemia (ALL) in remission who were treated with systemic chemotherapy only (CTO). Neurocognitive performances in 36 children and adolescents, aged 8.4-15.

Children in remission from acute lymphoblastic leukaemia: mental health, psychosocial adjustment and parental functioning.

Children in remission from acute lymphoblastic leukaemia: mental health, psychosocial adjustment and parental functioningThe objective of this study is to assess the mental health and psychosocial adjustment of children in remission from acute lymphoblastic leukaemia (ALL), and parental functioning compared to healthy controls. A cross-sectional study of 40 children treated for ALL (mean age 11.8 years, range 8.

Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only.

Objective: To examine cognitive outcome in children and adolescents with acute lymphoblastic leukaemia (ALL) in remission, treated with central nervous system prophylactic chemotherapy only.

Method: Thirty-five children and adolescents, age 8.4-15.

Health-related quality of life and intellectual functioning in children in remission from acute lymphoblastic leukaemia.

Aim: To evaluate the health-related quality of life (HRQOL) and intellectual functioning of children in remission from acute lymphoblastic leukaemia (ALL).

Methods: Children and adolescents treated for ALL (n = 40; mean age 11.8 years, range 8.